Cargando…
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
Of late, targeted protein degradation (TPD) has surfaced as a novel and innovative chemical tool and therapeutic modality. By co-opting protein degradation pathways, TPD facilitates complete removal of the protein molecules from within or outside the cell. While the pioneering Proteolysis-Targeting...
Autores principales: | Alabi, Shanique B., Crews, Craig M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131913/ https://www.ncbi.nlm.nih.gov/pubmed/33839157 http://dx.doi.org/10.1016/j.jbc.2021.100647 |
Ejemplares similares
-
Mutant-selective degradation by BRAF-targeting PROTACs
por: Alabi, Shanique, et al.
Publicado: (2021) -
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
por: Ahn, Green, et al.
Publicado: (2021) -
PROTAC targeted protein degraders: the past is prologue
por: Békés, Miklós, et al.
Publicado: (2022) -
IGF2 Peptide-Based LYTACs for Targeted Degradation of Extracellular and Transmembrane Proteins
por: Mikitiuk, Michał, et al.
Publicado: (2023) -
Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation
por: Bond, Michael J., et al.
Publicado: (2021)